Search results
CDC warns of ADHD drug disruptions; telehealth firm execs accused of scheme that gave easy access to...
WIBW Topeka· 18 hours agoTop executives of a California-based online mental health company were arrested on allegations of...
Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say
San Jose Mercury News· 14 hours agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients,...
California Governor Gavin Newsom Announces CalCompetes Program Reaches $50 Billion of Private...
Sierra Sun Times· 12 hours ago...companies such as Bosch to domestically design, develop, and manufacture the next generation of...
CEO arrested and accused of running an Adderall drug ring
INSIDER via Yahoo News· 15 hours agoThe DOJ says the executives raked in $100 million by doling out millions of phony prescriptions. The...
California telehealth execs charged in ADHD prescription scheme amid nationwide med shortage
Los Angeles Times· 1 day agoAs many as 50,000 U.S. patients’ access to treatment for attention deficit hyperactivity disorder...
Drug dealer sentenced to 6 years in Marine’s fentanyl overdose death
Marine Corps Times via Yahoo News· 14 hours agoAn Oceanside, California, woman has been sentenced to more than six years in federal prison for...
JD Supra: California Supreme Court Will Review Novel Negligence Theory for Pharmaceutical...
JD Supra· 9 hours agoThe plaintiffs alleged that the pharmaceutical manufacturer Gilead acted negligently by postponing the development of a new HIV drug that was equally efficacious but had a ...
ADHD drug shortage possible after telehealth company is busted for fraud
AOL· 13 hours agoFederal officials are warning of a possible ADHD drug shortage after a subscription-based telehealth...
CDC warns access to ADHD meds may be disrupted
WBAL-TV Baltimore· 7 hours agoStates. On Thursday, the U.S. Centers for Disease Control and Prevention issued an official health advisory warning about a "potential disrupted access...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 1 day agoCEO, John Furner, told Bloomberg News that shoppers who picked up prescriptions for GLP-1 drugs at...
